Panish | Shea | Boyle | Ravipudi LLP attorney Pete Kaufman
specializes in mass tort pharmaceutical and
medical device litigation. Formerly a shareholder in the Florida-based
national mass tort litigation firm Levin, Papantonio P.A., Mr. Kaufman joined
Panish | Shea | Boyle | Ravipudi LLP in 2010 and has recovered hundreds of
millions of dollars for his clients.
Recognized as a Best
Lawyer in America in the areas of Plaintiffs Personal Injury
Litigation and Mass Tort Litigation/Class Actions, Mr. Kaufman has tried
cases in numerous pharmaceutical and medical device litigations including
Accutane, Vioxx, Phenylpropanolamine (PPA), Fen-Phen/diet drugs, Adderall and
the ASR Hip Replacement Device. Since 2001, he has received verdicts in excess
of $50 million, settlements of nearly $300 million and played a central role in
a number of national pharmaceutical and device litigations.
Currently, Mr. Kaufman also represents plaintiffs in cases
against Allergan resulting from the July 2019 worldwide
recall of Allergan BIOCELL® textured breast implants and tissue expanders due
to an uncommon incidence of Breast Implant-Associated Anaplastic Large Cell
Lymphoma (BIA-ALCL), a rare cancer of the immune system. In February 2020, he
was appointed to serve on the Plaintiffs
Executive Committee in the Allergan BIOCELL Textured Breast Implant
Products Liability Litigation.
Previously, Mr. Kaufman was a member of the leadership in
the ASR and Pinnacle Hip JCCPs, served on the Plaintiff’s Steering Committee
for the Pinnacle Hip Multi-District Litigation (MDL), and he was the co-chair
of the Trial Package committee for the Vioxx MDL, which resulted in a $4.7
billion national settlement. He also served on the Discovery and Science
committees in the Vioxx litigation and tried Vioxx cases in New Jersey,
Louisiana, Florida and California. In the Bextra/Celebrex litigation, Mr.
Kaufman was a member of the MDL Plaintiff’s Steering Committee and resolved
hundreds of cases involving plaintiffs who suffered heart attacks and strokes.
In the coordinated Baycol litigation, in state court in Philadelphia,
Pennsylvania, Mr. Kaufman served on the discovery and deposition committees,
worked with leading medical experts on a major national class action case, and
settled nearly 100 individual cases. He has also resolved claims related to
Stevens-Johnson Syndrome, the drugs Rezulin and Ketek, for liver related
injuries, Accutane, and numerous other personal injury cases.
In 2019, Mr. Kaufman won appeals in Pennsylvania Superior
Court finding that a
Japanese manufacturer was subject to personal jurisdiction in Pennsylvania, and
that
cases involving it and its American sister corporations had to proceed in
Philadelphia,
after defendants sought to have the case transferred. Vaughan Estate of Vaughan
v.
Olympus America, Inc. (Pa. Super. Ct. 2019) 208 A.3d 66, reargument denied
(June 11,
2019). In 2009, Mr. Kaufman handled one of the first cases in the country
against a
generic drug manufacturer, in which the court held that generic manufacturers
of drugs
have the same liability as brand-name manufacturers, Munroe v. Barr
Laboratories Inc.,
2009 WL 4047949 (N.D.Fla., 2009). Currently, Mr. Kaufman’s practice is focused
primarily on medical device litigation.
In addition to his work in mass tort litigation, Mr. Kaufman
handles catastrophic personal
injury cases throughout California. Since 2017, he has resolved cases involving
school
districts (2019, Ventura Unified School District – $16,000,000), agricultural
and trucking
companies (2018, Bakersfield – $21,000,000), medical malpractice, including
multiple
cases involving Ronald Reagan UCLA Medical Center totaling $16,000,000 (2017,
2018). In 2017, Mr. Kaufman won a verdict finding the owners of a Palm Springs
motel were personally responsible for the death of a guest who was tragically
killed by carbon
monoxide poisoning.
A frequent speaker on pharmaceutical litigation, covering
topics such as scientific evidence, trial preparation and case selection
criteria, Mr. Kaufman received his Bachelor of Arts degree, with honors, from
the University of Wisconsin-Madison and his law degree from University of
Florida Fredric G. Levin College of Law. Mr. Kaufman is a veteran of the United
States Army and a graduate of the Defense Language Institute. He served with
the 3d Armored Division, 533d Military Intelligence Battalion in Operations
Desert Shield and Desert Storm.
Mr. Kaufman is licensed to practice law in California and
Florida and before the United States Court of Appeals for the Eleventh Circuit,
the United States District Court for the Central District of California and the
United States District Court for the Northern and Middle Districts of Florida.